Are open-source approaches the most efficient way forward for COVID-19 drug discovery?-Reference-Cited by-同舟云学术

Are open-source approaches the most efficient way forward for COVID-19 drug discovery?

Published:2020-09-11 Issue:2 Volume:16 Page:115-117
ISSN:1746-0441
Container-title:Expert Opinion on Drug Discovery
language:en
Short-container-title:Expert Opinion on Drug Discovery

Author:

Harky Amer¹²³^ORCID,Mishra Vaibhav⁴,Ansari Daniyal Matin⁴^ORCID,Melamed Naomi⁴^ORCID

Affiliation:

1. Department of Cardiothoracic Surgery, Liverpool Heart and Chest Hospital, Liverpool, UK

2. Faculty of Life Sciences, University of Liverpool, Liverpool, UK

3. Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart and Chest Hospital, Liverpool, UK

4. Cranmer Terrace, St George’s, University of London, UK

Publisher

Informa UK Limited

Subject

Drug Discovery

Link

https://www.tandfonline.com/doi/pdf/10.1080/17460441.2020.1820983

Reference15 articles.

1. Six Laws of Open Source Drug Discovery

2. Open Source Drug Discovery in Practice: A Case Study

3. India Takes an Open Source Approach to Drug Discovery

4. The case for open-source software in drug discovery

5. RXRX19: the first morphological imaging dataset on SARS-CoV-2 virus. Rxrx.ai, 2020. [Last accessed 2020 Aug 3]. Available from: https://www.rxrx.ai/rxrx19#Download

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Artificial Intelligence in Drug Discovery: A Bibliometric Analysis and Literature Review;Mini-Reviews in Medicinal Chemistry;2024-08

2. A review on Coronavirus Disease and potentially active drugs targeting Coronavirus;Biomedical and Biotechnology Research Journal (BBRJ);2021